Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion

Por Van Acker, Heleen H., Anguille, Sébastien, De Reu, Hans, Berneman, Zwi N., Smits, Evelien L., Van Tendeloo, Viggo F.
Publicado no Front Immunol (2018)

Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity

Por Van den Bergh, Johan, Willemen, Yannick, Lion, Eva, Van Acker, Heleen, De Reu, Hans, Anguille, Sébastien, Goossens, Herman, Berneman, Zwi, Van Tendeloo, Viggo, Smits, Evelien
Publicado no Oncotarget (2015)

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing

Por Campillo-Davo, Diana, Fujiki, Fumihiro, Van den Bergh, Johan M. J., De Reu, Hans, Smits, Evelien L. J. M., Goossens, Herman, Sugiyama, Haruo, Lion, Eva, Berneman, Zwi N., Van Tendeloo, Viggo
Publicado no Front Immunol (2018)

A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches

Por Versteven, Maarten, Van den Bergh, Johan M.J., Broos, Katrijn, Fujiki, Fumihiro, Campillo-Davo, Diana, De Reu, Hans, Morimoto, Soyoko, Lecocq, Quentin, Keyaerts, Marleen, Berneman, Zwi, Sugiyama, Haruo, Van Tendeloo, Viggo F.I., Breckpot, Karine, Lion, Eva
Publicado no Oncotarget (2018)